Procter & Gamble Health Q4 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,220.50
117.55 (2.30%)
117.55 (2.30%)Volume745.00
Updated: Wed 13 May, 2026 | 15:29:43
NSE
5,220.00121.00 (2.37%)
121.00 (2.37%)Volume11.33 K
Updated: Wed 13 May, 2026 | 15:29:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Jun 24
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q4 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Dec 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 262.98 | 269.30 | 37.05% |
| Depreciation/ Amortization | 7.16 | 5.90 | 4.68% |
| Operating Income | 20.90 | 104.56 | -65.51% |
| Net Income | 16.78 | 77.59 | -63.96% |
| Other Operating Expenses Total | 107.83 | 91.77 | 71.92% |
| Net Income Before Taxes | 22.83 | 108.82 | -63.60% |
| Total Revenue | 283.88 | 373.86 | 12.44% |
| Selling/ General/ Admin Expenses Total | 48.63 | 61.81 | 0.35% |
| Diluted Normalized EPS | 19.03 | 46.74 | -32.03% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.